www.interpharma.co.th Inter Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th a surge in revenues from sales of
% growth of revenue from sales of house and condominium units and 71% increase in revenue from rental and services attributed to the rise of total revenue. 2Q19 Net profit at THB 192m, or 56% decline YoY
100.78% when comparing to the same period of last year. Sale of low-rise residential units was THB 632.82 million, an increase of THB 52.36 million or 9% when comparing to the same period of last year
or 105.28%. Sale of low-rise residential units was THB 673.29 million, an increase of THB 167.71 million or 33.2% when comparing to the same period of last year which was 2018 2017 Increase (Decrease
of real estate business increased by THB 509.14 million or 43.49% when comparing to the same period of last year. Sale of low-rise residential units was THB 808.77 million, an increase of THB 175.94
increased 0.9% when comparing to the year 2016 (in 2016: 8.2% / in 2017: 9.1%). This was due to an increase in promotion expenses to stimulate sale. In 2017, 5 low-rise housing projects was launched together
& vaccination) was on par with the previous year. This trend also incurred to IPD income with IPD visit number barely changed yoy. while revenue per visit has increased by 10% yoy. The increase of revenue per
8,875m, increased by 128% YoY. Major drivers of such growth were 298% increase in revenue from sales of house and condominium together with 38% increase in revenue from rental and services which mainly
”) reported 2019 total revenue of THB 12,275m, increased by 63% YoY. Major drivers of such growth were 104% increase in revenue from sales of house and condominium together with 27% increase in revenue from
and after such events in two separate periods: (1) dividend declaration; (2) change of par value resulting in an increase or decrease in the number of shares; (3) grant of rights to subscribe newly